Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Cochran's Q Test01:17

Cochran's Q Test

Cochran's Q Test is a nonparametric statistical test used to determine if there are potential differences in the outcomes of three or more related groups on a binary (yes/no) or dichotomous outcome. It is essentially an extension of the McNemar Test, which is limited to two related samples - Cochran's Q test can handle three or more related samples, making it more versatile in scenarios where subjects are measured under multiple conditions. The test statistic follows a Chi-Square distribution,...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Controls in Experiments01:13

Controls in Experiments

When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world outcomes using the Tandem Mobi insulin pump with Control-IQ+ technology and Dexcom G7.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same author

Cost-Effectiveness of Control-IQ+ Technology in Insulin-Treated Patients With Type 2 Diabetes in the United States.

Diabetes, obesity & metabolism·2026
Same author

Situational awareness predicts self-management of type I diabetes in adolescents and young adults.

Health psychology : official journal of the Division of Health Psychology, American Psychological Association·2026
Same author

HEDIS glycemic goal achieved using control-IQ Technology.

The American journal of managed care·2026
Same author

Automated Insulin Delivery Is Beneficial in Adults With Insulin-Treated Type 2 Diabetes With and Without GAD65 Antibodies.

Diabetes care·2025
Same author

Additive Benefits of Control-IQ+ AID to GLP-1 Receptor Agonist Use in Adults With Type 2 Diabetes.

Diabetes care·2025

Related Experiment Video

Updated: Jun 11, 2026

Functional Interrogation of Adult Hypothalamic Neurogenesis with Focal Radiological Inhibition
11:45

Functional Interrogation of Adult Hypothalamic Neurogenesis with Focal Radiological Inhibition

Published on: November 14, 2013

First Use of Control-IQ+ Technology in Newly Indicated Populations.

Kimia Z Assadi1, Edwin W D'Souza1, Jordan E Pinsker1

  • 1Tandem Diabetes Care, San Diego, California, USA.

Diabetes Technology & Therapeutics
|June 10, 2026
PubMed
Summary
This summary is machine-generated.

Control-IQ+ technology effectively manages glucose levels for diverse insulin users, achieving high automation and time in range. Advanced features are underutilized but not essential for optimal glycemic control.

Keywords:
Control-IQ+Tandem Mobiautomated insulin deliverydiabetest:slim X2

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Using High Content Imaging to Quantify Target Engagement in Adherent Cells
07:23

Using High Content Imaging to Quantify Target Engagement in Adherent Cells

Published on: November 29, 2018

Related Experiment Videos

Last Updated: Jun 11, 2026

Functional Interrogation of Adult Hypothalamic Neurogenesis with Focal Radiological Inhibition
11:45

Functional Interrogation of Adult Hypothalamic Neurogenesis with Focal Radiological Inhibition

Published on: November 14, 2013

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Using High Content Imaging to Quantify Target Engagement in Adherent Cells
07:23

Using High Content Imaging to Quantify Target Engagement in Adherent Cells

Published on: November 29, 2018

Area of Science:

  • Endocrinology
  • Diabetes Technology
  • Metabolic Diseases

Background:

  • Control-IQ+ technology is an algorithm update for Tandem t:slim X2 and Tandem Mobi insulin pumps.
  • It supports users with varied insulin needs and introduces extended bolus and temporary basal rates during automation.

Purpose of the Study:

  • To describe the early real-world utilization of Control-IQ+ technology.
  • To evaluate its performance in newly indicated populations with diverse total daily insulin (TDI) requirements.

Main Methods:

  • Retrospective analysis of data from 40,320 Control-IQ+ users (March-June 2025).
  • Data sourced from Tandem Source web application with ≥14 days and ≥70% continuous glucose monitoring (CGM) availability.
  • Users stratified into low (<10 units/day), moderate (10-100 units/day), and high (>100 units/day) TDI groups.

Main Results:

  • Median time in automation exceeded 90% across all TDI subgroups.
  • Overall median time in range (TIR) was 71.4%, with similar TIR in low (72.7%) and moderate (71.7%) TDI users.
  • Hypoglycemia rates were low across all groups; advanced features were used by a minority, most frequently in the low-TDI group.

Conclusions:

  • Control-IQ+ users achieve high automation and exceed glycemic goals, particularly those with low to moderate insulin needs.
  • Routine use of advanced features like extended bolus and temporary basal rates is not necessary for achieving therapeutic benefits.
  • Proactive engagement with advanced features may offer additional benefits but is not critical for Control-IQ+ efficacy.